HMGCR and atherosclerosis: Statins, also known as 3-hydroxy-3-methylglutaryl coenzyme-A reductase (HMG-CoA reductase) inhibitors, are commonly prescribed for either primary or secondary prevention of atherosclerotic cardiovascular disease (ASCVD) [2].